The study of BRCA1 mutation carriers and BRCA2 mutation carriers in The Netherlands is the first to prospectively follow healthy women, who opted for either BRRM or surveillance, in order to compare their overall risk of dying from any cause and their risk of dying from breast cancer. This means that the risk of dying from breast cancer was low for all BRCA2 mutation carriers, and there was no difference between the BRRM group and the surveillance group.
second Risk reduction of breast
Milestones in Cancer Research and Discovery. Resources for News Media. NCI Congressional Justification. Women at average risk should start talking to their doctors about breast cancer screening, likely with a mammogram, at age It is normally a tumour suppressor gene.
Women exposed to ionizing radiation during atomic bomb blasts during the Second World War also have a higher risk of developing breast cancer, especially if they were exposed during puberty. Your comments.